| Execution period | 5 years (FY 2026-27 to FY 2030-31) |
|---|
BSE filing, BSE: 544365. Summary written from the filing by ALFA Finder's alert engine.
Shanmuga Hospital Ltd: key numbers
- Share price
- ₹41.05
- Market cap
- ₹55.88 Cr
- Revenue (annual)
- ₹47.44 Cr
- Net profit (annual)
- ₹4.21 Cr
- P/E (TTM)
- 13.3×Sector 52.0×
- Promoter holding
- 72.35%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shanmuga Hospital Ltd
All →Shanmuga Hospital Product Launch
Shanmuga Hospital commercially launched its 'Shanmuga 360' healthcare mobile app on 20 October 2026. It offers medicine booking, lab tests, ambulance and home-care services.
Shanmuga Hospital Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory norms.
Shanmuga Hospital Capital Structure Change
Shanmuga Hospital's members approved an increase in authorized share capital from ₹14 Crore to ₹25 Crore at the 6th Annual General Meeting.
Shanmuga Hospital Management Change
Shanmuga Hospital Limited has appointed Mrs. S Anuradha as the new Secretarial Auditor. The appointment is for a term of 60 months.
Shanmuga Hospital Annual General Meeting
Shanmuga Hospital Ltd held its 6th Annual General Meeting on September 18, 2026, to discuss financial statements, director appointments, and various capital and ESOP resolutions.
Shanmuga Hospital Promoter Buying: ₹0.13 Cr
Promoter and Director Panneerselvam Prabu Sankar acquired shares of Shanmuga Hospital Ltd through open market purchases worth ₹0.13 Crore, increasing his stake by 0.22%.
- Value
- ₹0.13 Cr
- Promoter stake change
- +0.22%
Other other announcement announcements
All →KRN Heat Exchanger and Refrigeration Other Announcement
KRN Heat Exchanger filed its Reg 32 statement confirming no deviation in QIP fund use, with INR 349.99 Crore raised on 1 June 2026. The utilisation table reports no variation across the three objects.
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.